Prognostic and predictive effect of TP53 mutations in non-small cell lung cancer patients from adjuvant cisplatin-based therapy randomized trials: a LACE-bio pooled analysis.

Journal Thoracic Oncology

2016 Feb 16.
Prognostic and predictive effect of TP53 mutations in non-small cell lung cancer patients from adjuvant cisplatin-based therapy randomized trials: a LACE-bio pooled analysis..

Ma X, Le Teuff G, Lacas B, Tsao MS, Graziano S, Pignon JP, Douillard JY, Le Chevalier T, Seymour L, Filipits M, Pirker R, Janne P, Shepherd FA, Brambilla E, Soria JC, Hainaut P; collaborative LACE-Bio group.